TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
Non-trophoblastic tumours of the placenta
Key Statistics
- ~1% — Placentas with chorioangioma (microscopic)
- 1 in 3500–9000 — Births with ‘giant’ (>4cm) chorioangioma
- 8.2% — IUFD risk, expectant chorioangioma (95%CI 3.8–15.0%)
Don't-miss facts
-
Chorioangioma: ~1% of placentas; ‘giant’ (>4cm) in 1 in 3500–9000 births – complications mainly with tumours >4cm
-
Severe fetal anaemia = MCA PSV >1.50 MoM; polyhydramnios is the commonest complication (14–28%)
-
Avascular appearance on colour Doppler does NOT exclude chorioangioma diagnosis
-
Expectant IUFD risk 8.2% vs 23.6% after in-utero intervention (higher-risk cases selected for intervention)
-
All in-utero chorioangioma intervention should occur in a specialist fetal medicine centre with MDT/patient consensus
-
PMD vs GTD: βhCG usually normal in PMD; karyotype PMD = 46,XX/XY, partial mole = triploid – avoid erroneous termination
-
Teratoma vs fetus acardius amorphus: look for a rudimentary umbilical cord and axial skeletal organisation (present only in amorphus)
-
Placental metastasis carries 81% maternal mortality; melanoma, lung and gastric cancer are the commonest primaries
Tumour comparison at a glance
Chorioangioma – commonest, most complications if >4cm
Teratoma, leiomyoma, hepatocellular adenoma – rare, usually incidental/benign course PMD – 1/3 FGR, 1/3 IUFD risk, mimics GTD
Abbreviation Key
- PMD — placental mesenchymal dysplasia
- HELLP — haemolysis, elevated liver enzymes, low platelets
- GTD — gestational trophoblastic disease
- MDT — multidisciplinary team
- FGR — fetal growth restriction
- EMCS/ELCS — emergency/elective caesarean section
- IUFD — intrauterine fetal death
- NVD — normal vaginal delivery
- MCA PSV — middle cerebral artery peak systolic velocity
- TOP — termination of pregnancy
- MoM — multiples of the median
- 3D — three-dimensional
- AFP — alpha fetoprotein
- MRI — magnetic resonance imaging
- βhCG — beta human chorionic gonadotropin
- SSFSE — single-shot fast spin-echo sequence
Source: Le Vance J, Gurney L, Hodgetts Morton V. Non-trophoblastic tumours of the placenta: pathophysiology, diagnosis and management. The Obstetrician & Gynaecologist 2025;27:91–103. doi:10.1111/tog.12970
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).